Cargando…

Postoperative Prevention of Urinary Tract Infections in Patients after Urogynecological Surgeries—Nonantibiotic Herbal (Canephron) versus Antibiotic Prophylaxis (Fosfomycin Trometamol): A Parallel-Group, Randomized, Noninferiority Experimental Trial

Introduction and hypothesis: Urinary tract infections (UTIs) are one of the most common complications of urogynecological surgeries. The risk of UTIs is increased by the catheterization of the bladder, intraoperative cystoscopy, and urine retention after the procedure. Due to increasing antibiotic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wawrysiuk, Sara, Rechberger, Tomasz, Kubik-Komar, Agnieszka, Kolodynska, Aleksandra, Naber, Kurt, Miotla, Pawel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864930/
https://www.ncbi.nlm.nih.gov/pubmed/36678373
http://dx.doi.org/10.3390/pathogens12010027
_version_ 1784875709350543360
author Wawrysiuk, Sara
Rechberger, Tomasz
Kubik-Komar, Agnieszka
Kolodynska, Aleksandra
Naber, Kurt
Miotla, Pawel
author_facet Wawrysiuk, Sara
Rechberger, Tomasz
Kubik-Komar, Agnieszka
Kolodynska, Aleksandra
Naber, Kurt
Miotla, Pawel
author_sort Wawrysiuk, Sara
collection PubMed
description Introduction and hypothesis: Urinary tract infections (UTIs) are one of the most common complications of urogynecological surgeries. The risk of UTIs is increased by the catheterization of the bladder, intraoperative cystoscopy, and urine retention after the procedure. Due to increasing antibiotic resistance, there is a need to search for new methods of postoperative UTI prevention. Canephron is a mixture of century herbs, lovage roots, and rosemary leaves with diuretic, spasmolytic, anti-inflammatory, antibacterial, and nephroprotective properties. The aim of this study is to demonstrate the noninferiority of Canephron versus antibiotic prophylaxis with fosfomycin trometamol (FT), based on the collective results of postoperative urine culture analyses. Methods: One hundred and twenty-five female patients were randomized into two groups before undergoing urogynecological surgeries, including a control group (n = 67), which received one dose of 3 g of FT the day after the procedure, and a study group (n = 58), which received Canephron three times a day for 14 days, starting the day after the procedure. All the patients were assessed using the Acute Cystitis Symptom Score (ACSS). Results: UTIs were observed in 6.4% of the patients. There was no statistically significant difference between the use of FT and Canephron in terms of UTIs (Chi^2 N-1 = 0.8837; p = ns). Additional factors, such as menopausal status and the type of procedure performed, increased the risk of developing a UTI. Factors such as the body mass index (BMI) and parity had no correlation. Conclusions: Canephron is noninferior to FT in the prevention of postoperative UTIs. The use of such a phytotherapeutic drug may help to decrease antibiotic consumption, which is closely connected to the growing trend of antibiotic resistance.
format Online
Article
Text
id pubmed-9864930
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98649302023-01-22 Postoperative Prevention of Urinary Tract Infections in Patients after Urogynecological Surgeries—Nonantibiotic Herbal (Canephron) versus Antibiotic Prophylaxis (Fosfomycin Trometamol): A Parallel-Group, Randomized, Noninferiority Experimental Trial Wawrysiuk, Sara Rechberger, Tomasz Kubik-Komar, Agnieszka Kolodynska, Aleksandra Naber, Kurt Miotla, Pawel Pathogens Article Introduction and hypothesis: Urinary tract infections (UTIs) are one of the most common complications of urogynecological surgeries. The risk of UTIs is increased by the catheterization of the bladder, intraoperative cystoscopy, and urine retention after the procedure. Due to increasing antibiotic resistance, there is a need to search for new methods of postoperative UTI prevention. Canephron is a mixture of century herbs, lovage roots, and rosemary leaves with diuretic, spasmolytic, anti-inflammatory, antibacterial, and nephroprotective properties. The aim of this study is to demonstrate the noninferiority of Canephron versus antibiotic prophylaxis with fosfomycin trometamol (FT), based on the collective results of postoperative urine culture analyses. Methods: One hundred and twenty-five female patients were randomized into two groups before undergoing urogynecological surgeries, including a control group (n = 67), which received one dose of 3 g of FT the day after the procedure, and a study group (n = 58), which received Canephron three times a day for 14 days, starting the day after the procedure. All the patients were assessed using the Acute Cystitis Symptom Score (ACSS). Results: UTIs were observed in 6.4% of the patients. There was no statistically significant difference between the use of FT and Canephron in terms of UTIs (Chi^2 N-1 = 0.8837; p = ns). Additional factors, such as menopausal status and the type of procedure performed, increased the risk of developing a UTI. Factors such as the body mass index (BMI) and parity had no correlation. Conclusions: Canephron is noninferior to FT in the prevention of postoperative UTIs. The use of such a phytotherapeutic drug may help to decrease antibiotic consumption, which is closely connected to the growing trend of antibiotic resistance. MDPI 2022-12-23 /pmc/articles/PMC9864930/ /pubmed/36678373 http://dx.doi.org/10.3390/pathogens12010027 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wawrysiuk, Sara
Rechberger, Tomasz
Kubik-Komar, Agnieszka
Kolodynska, Aleksandra
Naber, Kurt
Miotla, Pawel
Postoperative Prevention of Urinary Tract Infections in Patients after Urogynecological Surgeries—Nonantibiotic Herbal (Canephron) versus Antibiotic Prophylaxis (Fosfomycin Trometamol): A Parallel-Group, Randomized, Noninferiority Experimental Trial
title Postoperative Prevention of Urinary Tract Infections in Patients after Urogynecological Surgeries—Nonantibiotic Herbal (Canephron) versus Antibiotic Prophylaxis (Fosfomycin Trometamol): A Parallel-Group, Randomized, Noninferiority Experimental Trial
title_full Postoperative Prevention of Urinary Tract Infections in Patients after Urogynecological Surgeries—Nonantibiotic Herbal (Canephron) versus Antibiotic Prophylaxis (Fosfomycin Trometamol): A Parallel-Group, Randomized, Noninferiority Experimental Trial
title_fullStr Postoperative Prevention of Urinary Tract Infections in Patients after Urogynecological Surgeries—Nonantibiotic Herbal (Canephron) versus Antibiotic Prophylaxis (Fosfomycin Trometamol): A Parallel-Group, Randomized, Noninferiority Experimental Trial
title_full_unstemmed Postoperative Prevention of Urinary Tract Infections in Patients after Urogynecological Surgeries—Nonantibiotic Herbal (Canephron) versus Antibiotic Prophylaxis (Fosfomycin Trometamol): A Parallel-Group, Randomized, Noninferiority Experimental Trial
title_short Postoperative Prevention of Urinary Tract Infections in Patients after Urogynecological Surgeries—Nonantibiotic Herbal (Canephron) versus Antibiotic Prophylaxis (Fosfomycin Trometamol): A Parallel-Group, Randomized, Noninferiority Experimental Trial
title_sort postoperative prevention of urinary tract infections in patients after urogynecological surgeries—nonantibiotic herbal (canephron) versus antibiotic prophylaxis (fosfomycin trometamol): a parallel-group, randomized, noninferiority experimental trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864930/
https://www.ncbi.nlm.nih.gov/pubmed/36678373
http://dx.doi.org/10.3390/pathogens12010027
work_keys_str_mv AT wawrysiuksara postoperativepreventionofurinarytractinfectionsinpatientsafterurogynecologicalsurgeriesnonantibioticherbalcanephronversusantibioticprophylaxisfosfomycintrometamolaparallelgrouprandomizednoninferiorityexperimentaltrial
AT rechbergertomasz postoperativepreventionofurinarytractinfectionsinpatientsafterurogynecologicalsurgeriesnonantibioticherbalcanephronversusantibioticprophylaxisfosfomycintrometamolaparallelgrouprandomizednoninferiorityexperimentaltrial
AT kubikkomaragnieszka postoperativepreventionofurinarytractinfectionsinpatientsafterurogynecologicalsurgeriesnonantibioticherbalcanephronversusantibioticprophylaxisfosfomycintrometamolaparallelgrouprandomizednoninferiorityexperimentaltrial
AT kolodynskaaleksandra postoperativepreventionofurinarytractinfectionsinpatientsafterurogynecologicalsurgeriesnonantibioticherbalcanephronversusantibioticprophylaxisfosfomycintrometamolaparallelgrouprandomizednoninferiorityexperimentaltrial
AT naberkurt postoperativepreventionofurinarytractinfectionsinpatientsafterurogynecologicalsurgeriesnonantibioticherbalcanephronversusantibioticprophylaxisfosfomycintrometamolaparallelgrouprandomizednoninferiorityexperimentaltrial
AT miotlapawel postoperativepreventionofurinarytractinfectionsinpatientsafterurogynecologicalsurgeriesnonantibioticherbalcanephronversusantibioticprophylaxisfosfomycintrometamolaparallelgrouprandomizednoninferiorityexperimentaltrial